J. Védrenne

Chemothermotherapy in the management of retinoblastoma.

L. Desjardins, B. Asselain, J. Zucker, 2002, Ophthalmology.

Functional results after treatment of retinoblastoma.

L. Desjardins, B. Asselain, J. Zucker, 2002, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

Circulating macrophage colony stimulating factor as a marker of tumour progression.

X. Sastre, J. Cosset, P. Beuzeboc, 2002, European cytokine network.

Central nervous system lesions in hypomclanosis of Ito: an MRI and pathological study

C. Lacroix, M. Tardieu, P. Landrieu, 1993, Journal of Neurology.

Lithiase cholestatique néonatale associée à une infection à colibacilles

P. Saunier, J. Védrenne, K. Alissa, 1996 .

[Prevention of postoperative lymphocele after breast amputation].

H. Cody, B. Asselain, R. Salmon, 1985, Presse medicale.

Positive effect of regional analgesia (RA) in terminal stage paediatric chondrosarcoma: a case report and the review of the literature

M. Queinnec, J. Védrenne, M. Estève, 1999, PAIN.

[Metastatic breast cancer. Chemotherapy with adriamycin, vindesine, cyclophosphamide and 5 FU. Value of continuous 5 FU perfusion. Results of controlled trials].

P. Beuzeboc, V. Mosseri, A. Livartowski, 1989, Bulletin du cancer.

Central nervous system lesions in hypomelanosis of Ito: an MRI and pathological study.

C. Lacroix, M. Tardieu, P. Landrieu, 1993, Journal of neurology.

A comparative study of controlled-release morphine (CRM) suspension and CRM tablets in chronic cancer pain.

S. Donnadieu, F. Boureau, J. Ranchère, 1992, Journal of pain and symptom management.

[Intrathecal injection of morphine in the ambulatory treatment of neoplastic pain (lumbar route)].

A. Guillaume, J. Védrenne, M. Estève, 1986, Journal de chirurgie.

IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy.

C. Jasmin, A. Poggi, F. Puppo, 1996, Oncogene.